Therapeutic innovations, diminishing returns, and control rate preservation

JAMA. 2009 Nov 25;302(20):2254-6. doi: 10.1001/jama.2009.1679.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Angioplasty, Balloon, Coronary
  • Biomarkers / blood
  • Cardiovascular Agents / therapeutic use
  • Clopidogrel
  • Diagnosis, Differential
  • Electrocardiography
  • Evidence-Based Medicine
  • Humans
  • International Cooperation
  • Metoprolol / therapeutic use
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy
  • Randomized Controlled Trials as Topic*
  • Streptokinase / therapeutic use
  • Therapeutics* / economics
  • Therapeutics* / statistics & numerical data
  • Therapeutics* / trends
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / therapeutic use
  • Treatment Outcome*
  • Troponin / blood

Substances

  • Biomarkers
  • Cardiovascular Agents
  • Troponin
  • Clopidogrel
  • Streptokinase
  • Metoprolol
  • Ticlopidine